SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-20-003102
Filing Date
2020-01-07
Accepted
2020-01-07 17:03:23
Documents
1
Group Members
ASILOMAR ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d863744dsctota.htm SC TO-T/A 22852
  Complete submission text file 0001193125-20-003102.txt   24373
Mailing Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411
Business Address 2-5-1, NIHONBASHI-HONCHO CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-T/A

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Subject) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-89574 | Film No.: 20513860
SIC: 2836 Biological Products, (No Diagnostic Substances)